Tel: (613) 742-8225
/
info@pdci.ca
Newsletter Sign-Up
Login to PDCI Services
Contact Us
Navigation
Home
About Us
What We Do
Develop Effective P&R Strategies
Establish Optimal Pricing
Demonstrate Value
Achieve Timely Market Access
Our Team
Careers
Services
Case Studies
News & Events
News
Events
Resources
Provincial & CDR Deadlines
Provincial and NIHB Formulary Publishing Dates
Common Drug Review (CDR) Submission Deadlines and CDEC Meeting Dates
PMPRB
PMPRB 36 Month Exchange Rates
PMPRB CPI Adjustment Factors Allowable Price Increases
PMPRB HDAP Meeting Dates & Submission Deadlines
Links
Consultation Responses
Blog
Publications
We help Pharma / Biotech firms:
Develop Effective
P&R Strategies
More Info
Establish Optimal
Pricing
More Info
Demonstrate
Value
More Info
Achieve Timely
Market Access
More Info
What's New
22
Feb
CADTH Pharmaceutical Reviews Update – Issue 5
Read More
15
Feb
Status Summary of Innovative Medicine pCPA Negotiations as of January 31, 2019
Read More
11
Feb
Expensive Drugs for Rare Diseases – Provincial Working Group Consultation
Read More
07
Feb
CADTH Launches New Parallel Scientific Advice Program
Read More
04
Feb
Observations on National Pharmacare from John-Paul Dowson
Read More
17
Jan
Status Summary of Negotiations on Brand Name Drugs as of December 31, 2018
Read More
08
Jan
All 2019 HDAP Meeting Dates Released
Read More
20
Dec
CADTH Releases Pharmaceutical Review Update Issue 4
Read More
19
Dec
Holiday Greetings
Read More
12
Nov
New INESSS Website Launched
Read More
02
Nov
PMPRB October 2018 NEWSletter Released
Read More
23
Oct
Register for the Market Access Summit and Save 20% with PDCI
Read More
23
Oct
Welcome PDCI New Hires!
Read More
01
Oct
REMINDER: PDCI is Sharing Responses to the National Pharmacare Consultation
Read More
28
Aug
PDCI Sharing Responses to Pharmacare Consultation
Read More
27
Aug
PMPRB 2017 Annual Report Released
Read More
30
Jul
ANNOUNCEMENT – Courtney Abunassar
Read More
03
Jul
CADTH Publishes New CDR Guidelines & Therapeutic Review Process, providing Framework to Revise CDEC Recommendations
Read More
28
Jun
Health Canada, CADTH & INESS Collaborate on Aligned Drug Review Processes
Read More
14
Jun
pCPA Releases its Brand Process Guidelines
Read More
31
May
CADTH publishes CDR Update – Issue 136
Read More
22
May
Join PDCI at the 4th Annual Canadian Institute Pharma Symposium & Save 10% off Registration
Read More
11
May
PMPRB’s May 2018 NEWSletter Updates Guideline Reform Timelines
Read More
04
May
The pan-Canadian Pharmaceutical Alliance (pCPA): Negotiations Status Update
Read More
30
Apr
INESSS Updates Submission Guide, Checklists and Template Forms
Read More
19
Apr
Standing Committee on Health Publishes Report & Recommendations on National Pharmacare
Read More
12
Apr
New pCODR Patient Input Tip Sheet Available
Read More
12
Apr
Saskatchewan Budget 2018-19: Province to Provide HIV Medications at No Cost
Read More
12
Apr
The pan-Canadian Pharmaceutical Alliance (pCPA): Negotiations Status Update
Read More
05
Apr
INESSS Releases Additional Information on the Evaluation Process
Read More
29
Mar
Reminder: New prices for generics under pCPA/CGPA agreement become effective April 1st, 2018
Read More
21
Mar
CADTH Invites Stakeholder Feedback on Proposed Revisions to the pCODR Clinician Engagement Process
Read More
09
Mar
CADTH Common Drug Review Releases New Update
Read More
08
Mar
PMPRB March 2018 NEWSletter Released
Read More
27
Feb
Federal Finance Minister Unveils Advisory Council on the Implementation of National Pharmacare in Budget 2018
Read More
23
Feb
Québec Gazette Announces Draft Regulations for Implementation of Fees for INESSS Submissions
Read More
14
Feb
CADTH Common Drug Review Releases New Update
Read More
08
Feb
The pan-Canadian Pharmaceutical Alliance (pCPA): Negotiations Status Update
Read More
07
Feb
PMPRB Form 3 (R&D) Due Date Reminder
Read More
01
Feb
NEW PDCI Report finds Health Canada significantly overstates benefits & underestimates negative impact of its proposed regulatory amendments
Read More
30
Jan
INESSS Releases Additional Information – Requests for Changes of an Administrative Nature
Read More
29
Jan
Proposed Amendments To The Patented Medicines Regulations: A Critical Appraisal Of The Cost-Benefit Analysis
Read More
22
Jan
PMPRB myth busting (I): The imaginary link between Canadian price controls and R&D expenditures
Read More
15
Jan
The pan-Canadian Pharmaceutical Alliance (pCPA): Negotiations Status Update
Read More
21
Dec
CADTH Common Drug Review Releases New Update
Read More
20
Dec
Happy Holidays from PDCI Market Access
Read More
14
Dec
TODAY at 1 pm: Government of Canada Officials to Speak on Proposed Regulatory Amendments
Read More
11
Dec
PMPRB Releases Guidelines Scoping Paper with Overview of Potential New Framework
Read More
07
Dec
The pan-Canadian Pharmaceutical Alliance (pCPA): Negotiations Status Update
Read More
05
Dec
Health Canada releases proposed PMPRB Price Regulations – The Charge of the Price Brigade
Read More
04
Dec
PDCI Webinar: Proposed Amendments to Patented Medicines Regulations – What Patentees Need to Know
Read More
04
Dec
Manitoba Health Amends Submission Requirements
Read More
01
Dec
Proposed Amendments to Patented Medicines Regulations Announced
Read More
29
Nov
INESSS Releases Additional Information on the Continuous Evaluation Process
Read More
29
Nov
PDCI’s Top 5 Tips: Block 5
Read More
28
Nov
CADTH Common Drug Review Releases New Update
Read More
27
Nov
2017 Québec City Healthcare Industry Forum
Read More
16
Nov
INESSS Releases Additional Information on the Continuous Evaluation Process
Read More
16
Nov
CADTH Common Drug Review Releases New Update
Read More
08
Nov
The pan-Canadian Pharmaceutical Alliance (pCPA): Negotiations Status Update
Read More
08
Nov
INESSS Releases Additional Information on the Continuous Evaluation Process
Read More
08
Nov
National Pharmacare: No need for “Repeal & Replace” Canadian edition
Read More
03
Nov
INESSS Releases List of Drug Products Currently Being Reviewed Under the Continuous Evaluation Process
Read More
01
Nov
PMPRB 2016 Annual Report Released
Read More
31
Oct
PDCI is excited to announce another great addition to the PDCI team: John-Paul Dowson, Director, Reimbursement Strategy
Read More
30
Oct
PDCI Welcomes Jennifer Haig as Manager, HTA and Health Economics
Read More
18
Oct
RAMQ: October 2017 Update for the List of Medications
Read More
17
Oct
INESSS Releases Additional Information on the Continuous Evaluation of Drug Products – Mandatory Notification
Read More
12
Oct
CADTH Common Drug Review Releases New Update
Read More
11
Oct
The pan-Canadian Pharmaceutical Alliance (pCPA): Negotiations Status Update
Read More
29
Sep
PMPRB Hearing Panel Decision Released: Soliris
Read More
29
Sep
INESSS Releases Additional Information on the Continuous Evaluation of Drug Products
Read More
29
Sep
CADTH Common Drug Review Releases New Update
Read More
12
Sep
Revealing Payments to Physicians: “Health Leaders” going down the wrong road with the PMPRB.
Read More
12
Sep
CADTH Common Drug Review Releases New Update
Read More
11
Sep
The pan-Canadian Pharmaceutical Alliance (pCPA): Negotiations Status Update
Read More
08
Sep
Notice to Manufacturers – Medications Under Review for February 2018 List Update
Read More
23
Aug
NOW LIVE: PDCI’s Information Sharing Webpage: Responses to Health Canada’s Patented Medicines Regulations Consultation
Read More
22
Aug
Sharing Responses on Proposed Amendments to the Patented Medicines Regulations
Read More
21
Aug
Notice to Manufacturers – Clarification of List Update Schedule in 2018
Read More
14
Aug
CADTH Common Drug Review Releases CDR Update – Issue 126
Read More
09
Aug
The pan-Canadian Pharmaceutical Alliance (pCPA): Negotiations Status Update
Read More
28
Jul
Release of PMPRB Annual Report Delayed (Again) – So much for transparency…
Read More
25
Jul
2018 HDAP Meeting Schedule
Read More
14
Jul
CADTH Common Drug Review Releases New Update
Read More
13
Jul
Ontario Drug Benefit Act to Create and Implement OHIP+: Children and Youth Pharmacare Program
Read More
11
Jul
The pan-Canadian Pharmaceutical Alliance (pCPA): Negotiations Status Update
Read More
19
Jun
PDCI Market Access Webinar: New INESSS Submission Guidelines and Implementation of Pre-NOC Review Procedure
Read More
15
Jun
The pan-Canadian Pharmaceutical Alliance (pCPA): Negotiations Status Update
Read More
13
Jun
UPDATE: Québec – INESSS Submission Deadline for August 2017
Read More
09
Jun
CADTH Common Drug Review Releases New Update
Read More
09
Jun
PDCI Market Access Webinar: Information Session for Industry on New INESSS Submission Guidelines and Implementation of Pre-NOC Review Procedure
Read More
06
Jun
NEW: INESSS Releases New Submission Guidelines – Implementation of Pre-NOC Review Procedure
Read More
30
May
The PMPRB Releases its May 2017 NEWSletter
Read More
25
May
PDCI Market Access Webinar: Information Session for Industry on Proposed Amendments to Patented Medicines Regulations
Read More
16
May
Patented Medicines Regulations Consultation Open
Read More
16
May
The pan-Canadian Pharmaceutical Alliance (pCPA): Negotiations Status Update
Read More
03
May
PDCI Welcomes Strategic Partner John-Paul Dowson!
Read More
02
May
Join PDCI at 3rd Annual Canadian Institute Pharma Symposium
Read More
19
Apr
New NPDUIS Report Released – PMPRB Meds Entry Watch
Read More
19
Apr
New INESSS Questionnaires Released for Medicines Under Review
Read More
13
Apr
The pan-Canadian Pharmaceutical Alliance (pCPA): Negotiations Status Update
Read More
28
Mar
CADTH’s Updated Guidelines for the Economic Evaluation of Health Technologies – 4th Edition Now Available
Read More
17
Mar
New CADTH Processes and March Newsletter
Read More
16
Mar
The pan-Canadian Pharmaceutical Alliance (pCPA): Negotiations Status Update
Read More
15
Mar
CADTH Special Event: New Guidelines for the Economic Evaluation of Health Technologies: Canada
Read More
15
Mar
INESSS Manufacturer Appointments
Read More
17
Feb
PMPRB Form 3 Reminder
Read More
06
Feb
Kaitlyn Proulx appointed Managing Director
Read More
06
Dec
Health Canada Releases Guidance Document for Biosimilar Biologic Drug Submissions
Read More
02
Dec
PMPRB’s Phase 1 of Rethinking the Guidelines Public Comments Now Available
Read More
01
Dec
Alberta Changes Special Authorization Criteria for Coverage of INFLECTRA™ (infliximab)
Read More
28
Nov
Ontario Public Drug Programs Funds New Indications for INFLECTRA™ (infliximab)
Read More
23
Nov
PMPRB Vice Chair Re-appointed
Read More
09
Nov
Private Payer Product Listing Agreements in Canada – Second Joint Industry/Payer Survey Results – NOW AVAILABLE
Read More
31
Oct
Registration is Open for CAHR’s 6th Annual National Day
Read More
20
Oct
INESSS Manufacturer Appointments
Read More
13
Oct
The pan-Canadian Pharmaceutical Alliance (pCPA): Negotiations Status Update
Read More
11
Oct
Application of Generic Substitution to the Exceptional Access Program (EAP)
Read More
04
Oct
Addendum #1 to Ontario Guidelines for Drug Submission and Evaluation to the Ontario Public Drug Programs
Read More
28
Sep
Alberta Releases New Amendments to Price Policy
Read More
26
Sep
Ontario Releases New Amendments to Regulation 201/96 under the ODBA Regulation and Regulation 935 under the DIDFA Regulation
Read More
20
Sep
Ontario Releases Updated Guidelines for Drug Submission and Evaluation 2016
Read More
13
Sep
Feedback on Proposed Revisions to Patient Input Template for CDR and pCODR
Read More
08
Sep
The pCPA: Negotiations Status Update
Read More
26
Aug
Registration is Underway for the CAHR Market Access 201 Course
Read More
26
Aug
PDCI Market Access WEBINAR ‒ Possible 2nd Session September 8, 2016 (date tentative)
Read More
19
Aug
PMPRB 2015 Annual Report Released
Read More
17
Aug
The pan-Canadian Pharmaceutical Alliance (pCPA): Negotiations Status Update
Read More
12
Aug
PDCI Market Access WEBINAR ‒ Information Session on the PMPRB Guidelines Modernization Discussion Paper
Read More
10
Aug
PDCI Market Access WEBINAR ‒ Information Session on the PMPRB Guidelines Modernization Discussion Paper
Read More
05
Aug
The PMPRB Releases its July 2016 NEWSletter
Read More
29
Jul
SAVE THE DATE
Read More
21
Jul
PMPRB 2015 Annual Report
Read More
12
Jul
The pan-Canadian Pharmaceutical Alliance (pCPA): Negotiations Status Update
Read More
04
Jul
PMPRB Guideline Modernization – PDCI to hold Industry Information Sessions in August / September
Read More
27
Jun
PMPRB – Discussion Paper Released – Board Down to 2 Board Members as of June 27 – 2015 Annual Report Board Delayed
Read More
20
Jun
PDCI Releases NEW Report on pCPA Best Practices, Trends and Outlook
Read More
03
Jun
BC PharmaCare Upcoming Modernization of the Reference Drug Program
Read More
01
Jun
RAMQ: June 2016 Update for the List of Medications
Read More
26
May
CADTH CDR and pCODR Engagement with the pCPA
Read More
25
May
Nova Scotia Pharmacare Funds INFLECTRA™ (infliximab)
Read More
18
May
The pan-Canadian Pharmaceutical Alliance (pCPA): Negotiations Status Update
Read More
17
May
CADTH Releases Recommendations Report for Anti-Vascular Endothelial Growth Factor Drugs for Retinal Conditions
Read More
03
May
The PMPRB Releases its April 2016 NEWSletter
Read More
03
May
Seeking Participation in the 2016 Private Payer PLA Survey
Read More
22
Apr
New Drug Review Process Developed by INESSS for Stable Blood Products
Read More
19
Apr
The pan-Canadian Pharmaceutical Alliance (pCPA) Releases its April 1st, 2016 Update
Read More
11
Apr
The pCPA Releases First Principles for Subsequent Entry Biologics
Read More
30
Mar
New Implementation Dates for Revisions to the Procedure for Voluntary Withdrawal and Providing CDR Review Team’s Responses
Read More
30
Mar
Minimum Period of 120 Calendar Days for Advance Notification of Anticipated Submissions and Resubmissions for CADTH’s CDR and pCODR Programs
Read More
24
Mar
The PMPRB to Implement Next Steps Regarding the Compendium of Policies, Guidelines and Procedures in June 2016
Read More
24
Mar
Ontario’s CED Will No Longer Routinely Evaluate CDR- or pCODR-Reviewed Drug Products
Read More
15
Mar
Ontario Public Drug Programs Funds INFLECTRA™ (infliximab)
Read More
15
Mar
CADTH Call for Patient Input for INFLECTRA™ (Subsequent Entry Biologic)
Read More
10
Mar
CADTH Call for Patient Input for Etanercept SEB
Read More
10
Mar
Proposal to Amend Ontario Regulation 201/96 under the Ontario Drug Benefit Act to Update Cost-Sharing Arrangements for Non-Low Income Seniors under the Ontario Drug Benefit Program
Read More
29
Feb
PDCI Pharmacare Costing Study Report 2016 – Final
Read More
26
Feb
Update on Procedures for the CADTH Common Drug Review and pan-Canadian Oncology Drug Review: Mandatory Disclosure of a Submitted Drug Price
Read More
23
Feb
pCPA February Update – Federal Drug Plans officially join the pCPA and the full Office team is now in place
Read More
17
Feb
Ontario Listing of Inflectra
Read More
17
Feb
Alexion pCPA Negotiation
Read More
12
Feb
Alberta Health Releases Price Confirmation Tentative Dates
Read More
12
Feb
PMPRB NEW Report: Generics360 – Generic Drugs in Canada, 2014
Read More
12
Feb
Modifications to the Procedure for Filing a Drug Submission Application for Generic Drugs with INESSS
Read More
02
Feb
New Pilot Initiative: Increasing Opportunities for Clinical Input and Feedback in CADTH pan-Canadian Oncology Drug Review Process
Read More
20
Jan
C-MAP™ Canadian Drug Benefit Plans Reference Guide 2016 Edition NOW AVAILABLE!
Read More
18
Jan
PHARMACARE COSTING IN CANADA: Preliminary Report
Read More
21
Dec
PMPRB Releases Strategic Plan 2015-2018
Read More
14
Dec
Patented Medicine Prices Review Board Releases 2014 Annual Report
Read More
14
Dec
Updates to the Guidelines for the Economic Evaluation of Health Technologies: Canada
Read More
14
Dec
Québec Moves to Introduce a Tendering System for Drugs
Read More
04
Dec
Ontario Releases Summary of Minister’s Roundtable on Pharmacare
Read More
25
Nov
PDCI Strategic Advice Services for Product Listing Agreements
Read More
13
Nov
PMPRB wins at Federal Court of Appeal – Maintains jurisdiction over patented generic products
Read More
03
Nov
Presentation and Poll Results from PDCI Market Access Product Listing Agreement (PLA) Webinar is Now Available
Read More
26
Oct
CADTH: Extending Deadline on Consultation on Procedures for the CADTH Common Drug Review
Read More
26
Oct
CAHR National Day: National Approaches to Pharma Policy: International & Canadian Perspectives
Read More
20
Oct
PDCI Market Access WEBINAR ‒ Market Access Climate Change: the Evolving Impact of Product Listing Agreements
Read More
16
Oct
QUÉBEC: INESSS Upcoming Meetings with Manufacturers – June 2016 “Liste des médicaments”
Read More
16
Oct
pCPA October Update – Québec officially joins the pCPA & the pCPA Office is now operational
Read More
06
Oct
Expanding the CADTH Drug Review Process to Receive Patient Input Submissions from Individual Patients and Caregivers
Read More
30
Sep
Manulife DrugWatch™ & Private Payer Product Listing Agreement (PLA) Series
Read More
17
Sep
Private Payer Product Listing Agreement (PLA) Series
Read More
09
Sep
Private Payer Product Listing Agreement (PLA) Series
Read More
03
Sep
Private Payer Product Listing Agreement (PLA) Series
Read More
31
Jul
The PMPRB has released its July 2015 NEWSletter
Read More
27
Jul
Ontario Public Drug Programs Division
Read More
20
Jul
Exceptional Response to PDCI/H3 Private Payer PLA Survey
Read More
24
Jun
Private Payer PLA Survey
Read More
23
Jun
Australia’s Pharmaceutical Benefits Advisory Committee Recommends Substitution of Biosimilars
Read More
19
Jun
QUEBEC: INESSS Upcoming Meetings with Manufacturers – February 2016 “Liste des médicaments”
Read More
12
Jun
QUÉBEC – INESSS Submission Deadlines: 2015-2016
Read More
08
Jun
PDCI International Trends Series Part 5
Read More
27
May
BC: Updates to BC Drug Review Process and Submission Requirements
Read More
27
May
ON: Amendments to Ontario Regulation 201/96
Read More
26
May
PDCI International Trends Series Part 4
Read More
25
May
Canadian Organization for Rare Disorders (CORD) to release first ever Rare Disease Strategy
Read More
19
May
PDCI International Trends Series Part 3
Read More
14
May
PDCI International Trends Series Part 2
Read More
04
May
PDCI International Trends Series
Read More
10
Apr
WIB-Greater Montreal and the Technoparc Montréal Present a Conference on Drug Reimbursement in Quebec
Read More
10
Apr
Updates to the Manufacturer Submission Requirements in the Alberta Drug Benefit List (ADBL)
Read More
07
Apr
CADTH: Guidelines for Manufacturers on pCODR Application Fees Implemented
Read More
30
Mar
Rare Diseases Campaign
Read More
25
Mar
The pan-Canadian Oncology Drug Review (pCODR) is moving
Read More
25
Mar
PDCI Canadian Drug Claims Database FREE TRIAL now available!
Read More
12
Mar
CADTH Revised Category 1 Requirements for Tailored CDR Reviews
Read More
05
Mar
Guidelines for Manufacturers on Application Fees for pCODR
Read More
02
Mar
‘Successful CDR, pCODR & INESSS Submissions’ Workshop CANCELLED
Read More
23
Feb
Pan-Canadian Generics – Centralized Price Confirmation Process
Read More
09
Feb
Interview with pCPA on the Guidelines for Negotiations
Read More
04
Feb
CADTH Update for Patient Groups — January 2015
Read More
04
Feb
PMPRB Update – January 2015 NEWSletter
Read More
14
Jan
Drug products undergoing evaluation for the June 2015 “Liste des médicaments”
Read More
05
Jan
CDEC Final Recommendation for Inflectra Posted
Read More
22
Dec
Happy Holidays from PDCI!
Read More
14
Nov
PMPRB Has Released its October 2014 NEWSletter
Read More
06
Nov
Proposed Regulation Amendments to Establish a Pricing Framework for Generic Products
Read More
03
Nov
PDCI Career Opportunity
Read More
03
Nov
Voluntary Compliance Undertaking of Valeant Canada LP to PMPRB
Read More
24
Oct
Patented Medicines Prices Review Board (PMPRB) Outreach Sessions
Read More
22
Oct
Meetings with Manufacturers for the June 2015 “Liste des médicaments”
Read More
16
Oct
IBM “Pan Canadian Drugs Negotiation Report” Now Available
Read More
08
Oct
Welcome Anita!
Read More
07
Oct
PDCI Pan-Canadian Pharmaceutical Alliance (PCPA) Benchmarking Survey Report – NOW AVAILABLE!
Read More
03
Oct
CADTH Updates for Patient Groups
Read More
02
Oct
PMPRB: The PMPRB Launches its New Website
Read More
02
Oct
QUEBEC: October Update for the “Liste des médicaments”
Read More
18
Sep
PMPRB: New enhanced PMPRB website coming soon
Read More
16
Sep
PMPRB: 2013 Annual Report Released
Read More
16
Sep
CADTH: Revised Guidelines for Manufacturers on Application Fees
Read More
18
Aug
15th Anniversary Edition of the C-MAP™ Canadian Drug Benefit Plans Reference Guide
Read More
06
Aug
CADTH Direct-Acting Antivirals for Chronic Hepatitis C Genotype 1
Read More
05
Aug
PMPRB has released its July 2014 NEWSletter
Read More
31
Jul
CADTH: Feedback Requested on Industry Application Fee Guidelines
Read More
30
Jul
CADTH: CDR Update – Issue 106
Read More
29
Jul
New Brunswick: Rare diseases drug plan established
Read More
24
Jul
pCODR: Summary Report from Stakeholder Consultations on Transfer of pCODR to CADTH
Read More
09
Jul
PMPRB 2013 Annual Report Delayed
Read More
08
Jul
CADTH: CDR Update – Issue 105 – Patient Input
Read More
08
Jul
QUEBEC: INESSS to have meetings with manufacturers for February 2015 Liste des médicaments update
Read More
27
Jun
PMPRB Federal Court Decision Appealed
Read More
16
Jun
QUEBEC: Submission deadlines published
Read More
29
May
PMPRB jurisdiction does not extend to Generics (Federal Court Decisions)
Read More
27
May
Update on pCODR Procedures and Guidelines Consultation
Read More
26
May
CADTH: Common Drug Review (CDR) Update – Issue 104
Read More
25
May
Invitation to attend PMPRB Outreach sessions
Read More
24
May
Common Drug Review (CDR) introduces new application fee for submissions
Read More
23
May
The PMPRB releases the April 2014 issue of its NEWSletter
Read More
23
May
Québec: Update to the Liste de médicaments
Read More
22
May
CADTH: CDEC to review Drugs for Rare Diseases via “enhanced” CDR process
Read More
20
Mar
Subsequent Entry Biologics in Canada: Stakeholders Discuss the Regulatory, Pricing and Reimbursement Landscape.
Read More
20
Mar
Executive Briefing Pharmaceutical Pricing and Reimbursement in Canada 2012 Edition
Read More
20
Mar
National Pharmacare Cost Impact Study
Read More
20
Mar
Generic Drug Prices: A Canada US Comparison
Read More
20
Mar
Canada’s Balance of Trade in Pharmaceuticals
Read More
20
Mar
Parliamentary Review of Bill C-91: Background Study on Drug Costs and Benefits
Read More
18
Feb
Actual CPI in 2013 and implications for PMPRB price compliance
Read More
18
Feb
Second phase of generic pricing policy implemented yesterday
Read More
18
Feb
Premier Announces New Catastrophic Drug Coverage Program
Read More
18
Feb
Generic drug prices drop to 35 per cent of brand
Read More
18
Feb
Provincial government invests $2.4 million in health research
Read More
18
Feb
INESSS to have meetings with manufacturers for June 2014 Liste des médicaments update
Read More
18
Feb
Update to the Liste de médicaments
Read More
18
Feb
High-income seniors to pay more for drugs
Read More
18
Feb
Price for top 10 generic drugs cut to 20% of brand price
Read More
18
Feb
New drugs on formulary expected to save $10 million/year
Read More
18
Feb
Province announces it will reimburse 100% of the costs of oral cancer drugs
Read More
18
Feb
120 new drugs added to Pharmacare last month
Read More
18
Feb
Some seniors’ and children’s prescriptions to cost more
Read More
18
Feb
Online processing to help Saskatchewan-based travellers receive six-month supplies of drugs
Read More
18
Feb
Province introduces Pharmaceutical Services Act
Read More
18
Feb
Drug manufacturer submission deadlines for listing on the AHWDBL have been updated
Read More
18
Feb
18% Generic Drug Pricing Policy Effective March 15, 2013
Read More
18
Feb
CDR Update — Issue 98
Read More
18
Feb
Environmental Scan on Subsequent Entry Biologics released
Read More
18
Feb
CADTH to post patient input submissions as of February 1, 2014
Read More
18
Feb
Canadian Drug Expert Committee (CDEC) Meeting Schedule
Read More
18
Feb
Effective April 1 2014: pCODR is transferring to CADTH
Read More
14
Feb
New PDCI Study!
Read More
14
Feb
Effective April 1 2014: pCODR is transferring to CADTH
Read More
13
Feb
PMPRB
Read More
12
Feb
CADTH
Read More